| 0 |
Osmotic Diuretic [EPC] |
12 |
0.0023 |
| 1 |
Tetracycline-class Antibacterial [EPC] |
4 |
0.0005 |
| 2 |
Lipopeptide Antibacterial [EPC] |
4 |
0.0004 |
| 3 |
CD22-directed Immunoconjugate [EPC] |
1 |
0.0003 |
| 4 |
Photoenhancer [EPC] |
1 |
0.0003 |
| 5 |
Oxazolidinone Antibacterial [EPC] |
6 |
0.0002 |
| 6 |
Sodium-Glucose Cotransporter 2 Inhibitor [EPC] |
16 |
0.0001 |
| 7 |
CD52-directed Cytolytic Antibody [EPC] |
2 |
0.0001 |
| 8 |
Topoisomerase Inhibitor [EPC] |
6 |
0.0001 |
| 9 |
Lipid-based Polyene Antifungal [EPC] |
1 |
0.0001 |
| 10 |
SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] |
1 |
0.0001 |
| 11 |
Platinum-based Drug [EPC] |
20 |
0.0001 |
| 12 |
Fluoroquinolone Antibacterial [EPC] |
9 |
0.0001 |
| 13 |
Nitroimidazole Antimicrobial [EPC] |
4 |
0.0001 |
| 14 |
Osmotic Laxative [EPC] |
15 |
0.0001 |
| 15 |
Nucleoside Metabolic Inhibitor [EPC] |
13 |
0.0000 |
| 16 |
Loop Diuretic [EPC] |
21 |
0.0000 |
| 17 |
Glycopeptide Antibacterial [EPC] |
3 |
0.0000 |
| 18 |
Nitrate Vasodilator [EPC] |
4 |
0.0000 |
| 19 |
Aminoglycoside Antibacterial [EPC] |
2 |
0.0000 |
| 20 |
Dietary Cholesterol Absorption Inhibitor [EPC] |
4 |
0.0000 |
| 21 |
Antimycobacterial [EPC] |
1 |
0.0000 |
| 22 |
Androgen Receptor Inhibitor [EPC] |
3 |
0.0000 |
| 23 |
Alkaloid [EPC] |
1 |
0.0000 |
| 24 |
Angiotensin Converting Enzyme Inhibitor [EPC] |
5 |
0.0000 |
| 25 |
BCL-2 Inhibitor [EPC] |
2 |
0.0000 |
| 26 |
Dihydrofolate Reductase Inhibitor Antibacterial [EPC] |
3 |
0.0000 |
| 27 |
Alkylating Drug [EPC] |
7 |
0.0000 |
| 28 |
Rifamycin Antibacterial [EPC] |
1 |
0.0000 |
| 29 |
Aromatase Inhibitor [EPC] |
3 |
0.0000 |
| 30 |
Polyene Antifungal [EPC] |
1 |
0.0000 |
| 31 |
General Anesthetic [EPC] |
1 |
0.0000 |
| 32 |
Angiotensin 2 Receptor Blocker [EPC] |
7 |
0.0000 |
| 33 |
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
1 |
0.0000 |
| 34 |
Peroxisome Proliferator Receptor alpha Agonist [EPC] |
1 |
0.0000 |
| 35 |
Corticosteroid [EPC] |
21 |
0.0000 |
| 36 |
HMG-CoA Reductase Inhibitor [EPC] |
6 |
0.0000 |
| 37 |
Dihydropyridine Calcium Channel Blocker [EPC] |
5 |
0.0000 |
| 38 |
Leukocyte Growth Factor [EPC] |
2 |
0.0000 |
| 39 |
Azole Antifungal [EPC] |
2 |
0.0000 |
| 40 |
Catecholamine [EPC] |
1 |
0.0000 |
| 41 |
Histamine-1 Receptor Antagonist [EPC] |
1 |
0.0000 |
| 42 |
Xanthine Oxidase Inhibitor [EPC] |
2 |
0.0000 |
| 43 |
Opioid Agonist [EPC] |
3 |
0.0000 |
| 44 |
Platelet Aggregation Inhibitor [EPC] |
5 |
0.0000 |
| 45 |
P2Y12 Platelet Inhibitor [EPC] |
1 |
0.0000 |
| 46 |
Histamine-2 Receptor Antagonist [EPC] |
1 |
0.0000 |
| 47 |
Interleukin-6 Receptor Antagonist [EPC] |
1 |
0.0000 |
| 48 |
alpha-Adrenergic Blocker [EPC] |
1 |
0.0000 |
| 49 |
Calcium [EPC] |
1 |
0.0000 |
| 50 |
CD20-directed Cytolytic Antibody [EPC] |
2 |
0.0000 |
| 51 |
Janus Kinase Inhibitor [EPC] |
1 |
0.0000 |
| 52 |
Phosphodiesterase 4 Inhibitor [EPC] |
1 |
0.0000 |
| 53 |
RANK Ligand Inhibitor [EPC] |
1 |
0.0000 |
| 54 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
6 |
0.0000 |
| 55 |
Mood Stabilizer [EPC] |
1 |
0.0000 |
| 56 |
Kinase Inhibitor [EPC] |
2 |
0.0000 |
| 57 |
beta-Adrenergic Blocker [EPC] |
1 |
0.0000 |
| 58 |
Atypical Antipsychotic [EPC] |
1 |
0.0000 |
| 59 |
Thalidomide Analog [EPC] |
1 |
0.0000 |
| 60 |
Benzodiazepine [EPC] |
1 |
0.0000 |